← Open Payments lookup

ASHLYN MONAGHAN: Open Payments

NPI 1265917256 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$994 in 58 payments from 14 companies in 2025. Trend: 2023 $658 · 2024 $412 · 2025 $994

Food & beverage: $994
CompanyPaymentsAmount
Novo Nordisk Inc16$247
Lilly USA, LLC12$201
PFIZER INC.5$82
Amgen Inc.5$82
Axsome Therapeutics, Inc.3$78
ABBVIE INC.4$72
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$44
AstraZeneca Pharmaceuticals LP2$33
Astellas Pharma US Inc2$31
GlaxoSmithKline, LLC.2$30

Products named: MOUNJARO, Ozempic, Wegovy, Auvelity, OTEZLA, JARDIANCE, NURTEC ODT, XIFAXAN.

Industry payments across TX — which companies pay providers there.